Ftse Mib
33.308,77
-1,09%
DAX
18.163,52
-0,41%
S&P 500
5.464,62
-0,16%
NASDAQ
17.689,36
-0,18%
Bitcoin
64.106,04
-0,22%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Global Cord Blood Corporation (CO) Global Cord Blood Corporation (CO) Notizie

CO

Global Cord Blood (CO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:CO
DataOraFonteTitoloSimboloCompagnia
25/04/202422:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
22/06/202315:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NYSE:COGlobal Cord Blood Corporation
02/06/202320:39Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
13/04/202321:14PR Newswire (US)GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALSNYSE:COGlobal Cord Blood Corporation
03/02/202320:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:COGlobal Cord Blood Corporation
03/02/202314:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:COGlobal Cord Blood Corporation
26/09/202222:07Business WireGlobal Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman IslandsNYSE:COGlobal Cord Blood Corporation
23/09/202220:07TipRanksGlobal Cord Blood trading halted by NYSE for ‘regulatory concern’NYSE:COGlobal Cord Blood Corporation
23/09/202219:52Business WireThe Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood CorporationNYSE:COGlobal Cord Blood Corporation
24/08/202215:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:COGlobal Cord Blood Corporation
16/08/202222:26Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NYSE:COGlobal Cord Blood Corporation
16/08/202222:16PR Newswire (US)Global Cord Blood Corporation Files Annual Report on Form 20-FNYSE:COGlobal Cord Blood Corporation
02/08/202214:01Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NYSE:COGlobal Cord Blood Corporation
06/07/202222:16PR Newswire (US)Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGMNYSE:COGlobal Cord Blood Corporation
05/07/202222:16PR Newswire (US)Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022NYSE:COGlobal Cord Blood Corporation
17/06/202218:49Dow Jones NewsGlobal Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for INDNYSE:COGlobal Cord Blood Corporation
16/06/202222:20PR Newswire (US)Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of MyelofibrosisNYSE:COGlobal Cord Blood Corporation
16/06/202222:05Business WireShareholders Led by Blue Ocean Announce Successful Results of Extraordinary General Meeting of Global Cord Blood CorporationNYSE:COGlobal Cord Blood Corporation
16/06/202214:30PR Newswire (US)Global Cord Blood Corporation Announces Purported EGM Is Not Validly ConvenedNYSE:COGlobal Cord Blood Corporation
15/06/202213:38Business WireShareholders of Global Cord Blood Corporation Are Reminded to Comply with the Rules of Conduct When Attending the Extraordinary General Meeting and Exercising Their Voting RightsNYSE:COGlobal Cord Blood Corporation
03/06/202215:17Business WireShareholders Led by Blue Ocean Call Extraordinary General Meeting of Global Cord Blood Corporation Shareholders to Terminate its Proposed Acquisition of Cellenkos, Inc. and Elect New BoardNYSE:COGlobal Cord Blood Corporation
27/05/202216:55Business WireBlue Ocean Announces Virgin Islands Court Grants Injunction Order Prohibiting Golden Meditech from Taking Any Steps on a Purported Share Charge from Blue Ocean or Pursuing the Removal of Blue Ocean’s Representative as a Director of Global Cord BloodNYSE:COGlobal Cord Blood Corporation
23/05/202222:54Business WireBlue Ocean Comments on Fraudulent Claims from Conflicted Party Golden Meditech Regarding Global Cord Blood CorporationNYSE:COGlobal Cord Blood Corporation
23/05/202212:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NYSE:COGlobal Cord Blood Corporation
10/05/202222:16PR Newswire (US)Global Cord Blood Corporation Announces Receipt of Blue Ocean PetitionNYSE:COGlobal Cord Blood Corporation
29/04/202222:16PR Newswire (US)Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products RightsNYSE:COGlobal Cord Blood Corporation
28/02/202222:16PR Newswire (US)Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022NYSE:COGlobal Cord Blood Corporation
23/02/202213:00PR Newswire (US)Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial ResultsNYSE:COGlobal Cord Blood Corporation
16/12/202122:16PR Newswire (US)Global Cord Blood Corporation Announces Rejection of Alternate Ocean ProposalNYSE:COGlobal Cord Blood Corporation
07/12/202114:32PR Newswire (US)Global Cord Blood Corporation Announces Results of 2021 Annual General MeetingNYSE:COGlobal Cord Blood Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:CO

La tua Cronologia

LSE
WPY
Worldpay
UPBT
OSTBTC
OST Simple Token
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network